ÂÜÀòÂÒÂ×

Annette Clancy has more than 30 years of experience in the pharmaceuticals industry, mainly at GlaxoSmithKline (GSK). She held several posts at GSK in the USA and the UK notably in R&D, global marketing and licensing strategy, and commercial development. Until 2008 she was Head of International Transactions and Alliance Management, responsible for delivering innovative partnerships on early-stage drugs, international commercial alliances and mergers and acquisitions. Since then, Annette has concentrated on working with healthcare biotech companies. She is currently a Non-Executive Director on the Board of two public companies ObsEva and SOBI, in addition to her role as Chair at Enyo. Annette is also a an operational investor at Jeito Capital, a Paris based venture capital group specialising in healthcare with a presence in Europe and the US.